Rothschild Redburn has downgraded MarketAxess (NASDAQ:MKTX) from Buy to Neutral and lowered its price target to $134 from $189 due to increased competition from Tradeweb and Trumid eroding its market share in electronic bond trading. Despite the downgrade, MarketAxess reported strong Q1 2026 financial results, exceeding EPS and revenue forecasts, and saw an increase in its U.S. high-grade estimated market share in May 2026. InvestingPro analysis suggests the stock is undervalued, even as competitive pressures have led to price competition and stagnation in electronic volume penetration.

O Shaughnessy Asset Management LLC significantly increased its stake in Archer Daniels Midland Company (NYSE:ADM) by 57.4% in the fourth quarter, acquiring 70,134 additional shares. This brings their total holding to 192,231 shares, valued at approximately $11.1 million. The company's shares were up 1.4% to $81.21, and Archer Daniels Midland has a "Hold" consensus rating from analysts with an average target price of $74.50.

Morgan Stanley has initiated coverage on CRISPR Therapeutics (NASDAQ:CRSP) with an equalweight rating and a $60.00 price target. The firm believes much of the near-term upside for Casgevy, the first FDA-approved CRISPR gene-editing therapy, is already priced into the stock, which they suggest may be overvalued by their Fair Value analysis. Future growth drivers include pediatric expansion for Casgevy and upcoming Phase 1b data for CTX310 in a cardiometabolic indication.

Morgan Stanley has maintained an Equalweight rating and a $207 price target on Oracle stock, despite a mixed quarterly performance that led to a post-earnings decline. The firm noted strong Cloud Infrastructure revenue growth but a deceleration in Cloud Applications, resulting in the stock trading below its 52-week high and appearing slightly overvalued according to InvestingPro. Oracle's remaining performance obligations increased significantly, and the company provided positive Q1 FY27 Cloud revenue and EPS guidance, reiterating its FY27 total revenue and EPS targets.

O Shaughnessy Asset Management LLC reduced its stake in Packaging Corporation of America (NYSE:PKG) by 14% in Q4, selling 6,472 shares and retaining 39,726 shares valued at $8.19 million. Despite revenue falling short of expectations, the company reported strong quarterly earnings of $2.40 per share against a $2.17 consensus and increased its quarterly dividend to $1.50 per share. Other hedge funds have also adjusted their positions in the company, while institutional investors collectively own 89.78% of the stock.

LPL Financial LLC increased its stake in Gilead Sciences (NASDAQ:GILD) by 4.4% in the fourth quarter, bringing its total holdings to over 1.08 million shares valued at approximately $132.9 million. Institutional investors collectively own about 83.7% of the company's stock. Gilead recently reported strong Q1 earnings, exceeding analyst expectations with $6.96 billion in revenue and $2.03 EPS, and declared a quarterly dividend of $0.82 per share.

ServiceNow executives, including CEO Bill McDermott, have canceled stock sale plans and McDermott is buying $3 million in shares, signaling strong confidence despite a sector-wide downturn fueled by "SaaSpocalypse" fears. The company's robust Q4 2025 financial performance, including 21% subscription revenue growth and a 57% free cash flow margin, along with a $5 billion share repurchase program, suggests management believes the stock is significantly undervalued. Analysts largely maintain a bullish stance, projecting significant growth and upside potential for ServiceNow.

Sound Group Inc. (Nasdaq:SOGP) is an AI-powered audio company in China with a market cap of US$48.3 million. The stock is currently trading at US$11.70, significantly below its estimated fair value of US$1.82k, indicating it is 99.4% undervalued. Recent performance includes a 596.4% increase over the past year, and the company became profitable this year with full-year 2025 earnings showing a net income of CN¥226.5m.

Janney Montgomery Scott LLC increased its stake in The Home Depot, Inc. (NYSE:HD) by 3.6% in the fourth quarter, bringing its total holdings to 451,541 shares valued at approximately $155.4 million. This move comes as Home Depot reported strong Q1 earnings, beating analyst expectations with $3.43 EPS and $41.77 billion in revenue, alongside a 4.8% year-over-year revenue increase. The company also announced a quarterly dividend of $2.33, reflecting an annualized yield of about 2.9%, maintaining a "Moderate Buy" consensus rating from analysts despite some market headwinds.

Janney Montgomery Scott LLC significantly increased its stake in Amgen Inc., adding 40,622 shares to reach a total holding of 431,053 shares valued at approximately $141.1 million. This increase follows Amgen's strong first-quarter earnings, which exceeded analyst expectations with EPS of $5.15 and revenue of $8.62 billion, up 5.8% year-over-year. Analysts maintain a "Hold" rating on Amgen, with a consensus target price of $354.12, as the company's obesity drug MariTide shows promising growth potential.